GLUCOBELL TECHNOLOGIES LLP

In their own words

Glucobell – Intelligent Diabetes Care & Monitoring Platform Glucobell is a digital health technology platform designed to improve diabetes prevention, monitoring, and long-term disease management through data-driven personalized care. The platform integrates blood glucose tracking, medication adherence monitoring, lifestyle management, risk assessment, and patient engagement tools into a single Application. Using advanced analytics and artificial intelligence, Glucobell helps patients identify glycemic trends, receive personalized health recommendations, and improve treatment compliance. The platform also enables healthcare professionals to remotely monitor patient health parameters, facilitating early intervention and reducing the risk of diabetes-related complications. The innovation lies in combining continuous health monitoring, predictive analytics, patient education, and telehealth-enabled care within an accessible mobile application. By leveraging technology to bridge gaps in diabetes management, Glucobell aims to improve clinical outcomes, enhance patient quality of life, and reduce healthcare costs associated with chronic disease management. Glucobell has the potential to scale across India and global markets, addressing the growing burden of diabetes through a technology-driven, patient-centric approach. The startup's objective is to create an AI driven solution to diabetic problems(daily insulin dosage,calories intake,sugar medicine changes,loss to follow up) which is put to patient only after doctors approval.

Written by the company on its public Startup India profile. Not verified by us.